| Business Summary | | Bioject
Medical
Technologies
Inc.
was
incorporated
in
1985
for
the
purpose
of
developing,
manufacturing
and
marketing
jet
injection
systems
for
needle-free
drug
delivery.
The
Company
licenses
its
technology
to
pharmaceutical
and
biotechnology
companies
for
whose
products
the
Company's
technology
provides
enhanced
market
acceptance
or
increased
medical
efficacy.
The
Company
also
sells
its
products
directly
to
healthcare
providers.
Since
its
formation,
the
Company
has
been
engaged
principally
in
organizational,
financing,
research
and
development,
and
marketing
activities.
Its
products
and
manufacturing
operations
are
subject
to
extensive
government
regulation,
both
in
the
United
States
and
abroad. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Bioject
Medical
Technologies
develops,
manufactures
and
markets
a
jet
injection
system
for
needle-free
drug
delivery.
For
the
three
months
ended
6/30/01,
revenues
rose
20%
to
$620
thousand.
Net
loss
applicable
to
Common
increased
10%
to
$1.4
million.
Revenues
reflect
an
increase
in
unit
sales
volumes
of
Serono
related
products.
Higher
loss
suffered
from
costs
related
to
the
Iject
disposable
and
other
new
products
developments
and
increased
S/G/A
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| James O'Shea, 56 Chairman,
Pres, CEO | $256K | J. Michael Redmond, 41 VP,
Bus. Devel. of Bioject Inc. | 195K | Richard Stout, M.D., 48 VP
of Clinical Affairs of Bioject Inc. | 122K | Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|